Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-30-16 | Jan-01-16 |
| | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Nuvectra | 48.8 | 27.1 | 7.4 | 1.3 |
| NeuroNexus | | | 5.2 | 3.9 |
| Total revenues [+] | 48.8 | 27.1 | 12.5 | 5.2 |
| Products | | | 9.3 | 5.2 |
| Services | | | 3.2 | |
| Revenue growth [+] | 80.3% | 116.0% | 139.3% | |
| Nuvectra | 80.3% | 266.8% | 460.2% | |
| NeuroNexus | | | 31.4% | |
| Cost of goods sold [+] | 23.0 | 14.4 | 6.4 | 3.4 |
| Cost of product sales | | | 4.8 | |
| Cost of services | | | 1.6 | |
| Gross profit | 25.8 | 12.7 | 6.1 | 1.9 |
| Gross margin | 52.9% | 46.7% | 48.7% | 35.6% |
| Selling, general and administrative | 54.4 | 42.7 | 28.5 | 10.5 |
| Research and development | 14.6 | 12.1 | 14.5 | 15.4 |
| Other operating expenses | | | 0.5 | 0.3 |
| EBITDA [+] | -41.7 | -41.0 | -35.2 | -23.8 |
| EBITDA growth | 1.8% | 16.6% | 47.5% | |
| EBITDA margin | -85.4% | -151.3% | -280.5% | -454.9% |
| Depreciation | 1.2 | 1.0 | 2.0 | 0.3 |
| EBITA | -42.9 | -41.9 | -37.1 | -24.1 |
| EBITA margin | -87.8% | -154.9% | -296.2% | -460.6% |
| Amortization of intangibles | 0.3 | 0.3 | 0.3 | 0.3 |
| EBIT [+] | -43.2 | -42.2 | -37.4 | -24.4 |
| EBIT growth | 2.3% | 12.9% | 53.2% | |
| EBIT margin | -88.4% | -155.9% | -298.4% | -466.1% |
| Interest expense, net [+] | -4.7 | -2.3 | -1.4 | |
| Interest expense | -3.6 | -2.0 | -1.3 | |
| Interest income | 1.1 | 0.3 | 0.1 | |
| Other income (expense), net [+] | -8.7 | -4.8 | -2.4 | |
| Other | -0.4 | -0.6 | 0.3 | |
| Pre-tax income | -47.2 | -44.8 | -38.4 | -24.4 |
| Income taxes | 0.0 | -0.1 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.1% | 0.0% | 0.0% |
| Net income | -48.1 | -44.6 | -38.4 | -24.4 |
| Net margin | -98.6% | -164.7% | -306.6% | -466.1% |
| |
| Basic EPS [+] | ($3.19) | ($4.23) | ($3.74) | ($2.38) |
| Growth | -24.7% | 13.1% | 57.1% | |
| Diluted EPS [+] | ($3.19) | ($4.23) | ($3.74) | ($2.38) |
| Growth | -24.7% | 13.1% | 57.1% | |
| |
| Shares outstanding (basic) [+] | 14.8 | 10.6 | 10.3 | 10.3 |
| Growth | 39.9% | 2.9% | 0.2% | |
| Shares outstanding (diluted) [+] | 14.8 | 10.6 | 10.3 | 10.3 |
| Growth | 39.9% | 2.9% | 0.2% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|